The FDA has approved over-the-counter sales for Flonase (fluticasone propionate), the nasal spray for allergies, its manufacturer said.

GlaxoSmithKline, which sells Flonase Allergy Relief, said it expected to have the OTC version available for retail sale in early 2015. The dosage will be the same as in the current prescription product, the company said in a press release on Thursday. It uses a metered spray system to deliver 50 mcg of active drug per actuation.

The OTC product's label will indicate that it provides temporary relief of major nasal and eye-related allergy symptoms, including runny nose, sneezing, nasal congestion, and watery and itchy eyes, according to GlaxoSmithKline.